GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Upper GI Tract/AGES-D Score and GERD

AGES-D Score and GERD

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated August 1, 2025

Quick Answer

The AGES-D score is a diagnostic tool developed to predict gastroesophageal reflux disease (GERD) with moderate-to-high accuracy by integrating demographic and high-resolution manometric (HRM) parameters. It was specifically designed to assist clinicians in evaluating patients with inconclusive reflux monitoring results, particularly when esophageal acid exposure time (AET) falls within the indeterminate range of 4–6%.


The AGES-D score is a diagnostic tool developed to predict gastroesophageal reflux disease (GERD) with moderate-to-high accuracy by integrating demographic and high-resolution manometric (HRM) parameters. It was specifically designed to assist clinicians in evaluating patients with inconclusive reflux monitoring results, particularly when esophageal acid exposure time (AET) falls within the indeterminate range of 4–6%.

### Key Features of the AGES-D Score:

1. **Purpose**:

  • The AGES-D score aims to provide a structured, quantitative approach to diagnosing GERD in patients with ambiguous pH monitoring results. It is particularly useful in cases where traditional diagnostic methods fail to yield conclusive results.

2. **Parameters Used**:

The AGES-D score is based on five independent predictors of GERD, which form the acronym "AGES-D":

  • **A**ge: Older age is associated with a higher likelihood of GERD.
  • **G**ender: Male sex is a significant risk factor for GERD.
  • **E**GJ (Esophagogastric Junction) Contractile Integral (EGJ-CI): Lower EGJ-CI values are indicative of a weakened anti-reflux barrier.
  • **S** LES–Crural Diaphragm Distance (LES-CD): A larger LES-CD distance suggests a greater separation between the lower esophageal sphincter (LES) and the diaphragmatic crura, often associated with hiatal hernia and GERD.
  • **D**istal Contractile Integral (DCI): Lower DCI values indicate impaired esophageal peristaltic function, which compromises acid clearance and increases the risk of reflux.

3. **Calculation**:

The AGES-D score is calculated using the following logistic regression equation:

```

AGES-D score = -0.6162 + (0.0222 × age) + (0.5917 if male) + (0.02298 × LES-CD) – (0.01771 × EGJ-CI) – (0.00037183 × DCI)

```

  • A cutoff score of **≥0.125** provides 73% sensitivity and 75% specificity for diagnosing GERD.

4. **Validation**:

  • The AGES-D score was validated using a cohort of 391 adult patients with GERD symptoms who underwent 24-hour pH or pH-impedance monitoring and HRM.
  • In the derivation cohort (n=261), the score achieved an area under the curve (AUC) of 0.76, and in the validation cohort (n=130), it achieved an AUC of 0.82, demonstrating strong reproducibility and diagnostic accuracy.

5. **Clinical Utility**:

  • The AGES-D score is particularly valuable for patients with inconclusive pH or impedance monitoring results (AET 4–6%), where traditional diagnostic methods cannot definitively confirm or rule out GERD.
  • It provides a practical and cost-effective tool that incorporates both demographic and manometric data to improve diagnostic certainty without requiring subjective maneuvers or additional impedance-based variables.

6. **Advantages Over Existing Scores**:

  • The AGES-D score is simpler than other diagnostic systems like the Milan, COuGH RefluX, and Lyon scores.
  • It relies solely on objective and routinely available HRM parameters, avoiding subjective measures such as symptom scoring or complex maneuvers like leg-raising.

7. **Limitations**:

  • The study was retrospective and conducted at a single center, which may limit the generalizability of the findings.
  • The tool has not yet been validated in prospective multicenter studies or across diverse ethnic populations.
  • The study excluded patients with indeterminate AET values (4–6%), which is the population for whom the score is ultimately intended, potentially introducing a selection bias.

8. **Future Research**:

  • Prospective multicenter studies are needed to externally validate the AGES-D score.
  • Research should also assess the score’s predictive value for treatment response and compare it directly with established reflux diagnostic models.

### Clinical Implications:

The AGES-D score represents a significant advancement in the diagnostic workup of GERD, particularly for cases where traditional reflux testing is inconclusive. By combining demographic factors (age and gender) with HRM metrics (EGJ-CI, LES-CD, and DCI), the score provides a comprehensive assessment of both structural and functional aspects of the esophagus. This makes it a valuable adjunct to traditional reflux testing, helping clinicians make more informed treatment decisions.

In summary, the AGES-D score is a robust, evidence-based tool that enhances GERD diagnosis by integrating easily obtainable parameters. While promising, further validation in diverse populations and clinical settings is necessary to confirm its utility and reliability in routine practice.

Related Q&A

Basal Crypt Dysplasia in Barrett's Esophagus: GUT | July 2026

Introduction: Barrett's esophagus (BE) is the principal precursor of esophageal adenocarcinoma. Early detection of neoplastic transformation is essential for preventing cancer progression. This review discusses basal crypt dysplasia (CD), an emerging histological entity that may...

High-Resolution Impedance Manometry after POEM: AJG | May 2026

Introduction: Assessing esophageal clearance after peroral endoscopic myotomy (POEM) is essential for evaluating treatment success in achalasia. Timed barium esophagram (TBE) is the current standard, but high-resolution impedance manometry (HRiM) may provide a radiation-free physiological...

Magnetic Sphincter Augmentation Provides Durable GERD Control : Ann Surg | Jun 2026

Introduction: Magnetic sphincter augmentation (MSA) has emerged as an effective surgical option for patients with gastroesophageal reflux disease (GERD) who continue to experience symptoms despite medical therapy. By augmenting lower esophageal sphincter function while preserving...

New Strategies Needed for Resistant H. pylori : Indian J Gastroenterol | Jun 2026

Introduction: Helicobacter pylori infection affects more than half of the global population and remains a major cause of peptic ulcer disease, gastric mucosal inflammation, and gastric cancer. Successful eradication is a cornerstone of gastrointestinal practice,...

Vonoprazan–Tetracycline Dual Therapy Simplifies H. pylori Rescue Treatment : Gastroenterology | June 2026

Introduction: Helicobacter pylori Infection eradication after prior treatment failure remains a major therapeutic challenge due to increasing antibiotic resistance, poor tolerability of multidrug regimens and declining adherence rates. Simplified rescue strategies with improved safety and...

H. pylori Eradication Reduces Cancer but Mortality Benefit Remains Fragile : Gastroenterology | June 2026

Introduction Helicobacter pylori Infection eradication is widely accepted as a key strategy for prevention of Gastric Cancer. Large meta-analyses have consistently shown reductions in gastric cancer incidence following eradication therapy, supporting global screening and treatment...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer